Satsuki Sumitani

1.4k total citations
40 papers, 1.1k citations indexed

About

Satsuki Sumitani is a scholar working on Cognitive Neuroscience, Psychiatry and Mental health and Clinical Psychology. According to data from OpenAlex, Satsuki Sumitani has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cognitive Neuroscience, 15 papers in Psychiatry and Mental health and 11 papers in Clinical Psychology. Recurrent topics in Satsuki Sumitani's work include Schizophrenia research and treatment (9 papers), Obsessive-Compulsive Spectrum Disorders (8 papers) and Functional Brain Connectivity Studies (8 papers). Satsuki Sumitani is often cited by papers focused on Schizophrenia research and treatment (9 papers), Obsessive-Compulsive Spectrum Disorders (8 papers) and Functional Brain Connectivity Studies (8 papers). Satsuki Sumitani collaborates with scholars based in Japan and Australia. Satsuki Sumitani's co-authors include Tetsuro Ohmori, Shuichi Ueno, Shin’Ya Tayoshi, Jun‐ichi Iga, Shusuke Numata, Sumiko Shibuya‐Tayoshi, Masahito Nakataki, Masafumi Harada, Masahito Tomotake and Kyoko Taniguchi and has published in prestigious journals such as PLoS ONE, Journal of Affective Disorders and Psychiatry Research.

In The Last Decade

Satsuki Sumitani

39 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satsuki Sumitani Japan 19 419 331 267 209 191 40 1.1k
Shin’Ya Tayoshi Japan 14 288 0.7× 232 0.7× 229 0.9× 170 0.8× 89 0.5× 16 750
Malte S. Depping Germany 17 313 0.7× 422 1.3× 205 0.8× 161 0.8× 149 0.8× 22 972
Henning Witthaus Germany 14 521 1.2× 624 1.9× 183 0.7× 183 0.9× 137 0.7× 16 1.1k
Anna Walter Switzerland 18 304 0.7× 364 1.1× 154 0.6× 219 1.0× 85 0.4× 24 889
Clifford Cassidy Canada 21 567 1.4× 381 1.2× 333 1.2× 244 1.2× 236 1.2× 50 1.4k
Jun Ku Chung Canada 20 661 1.6× 410 1.2× 251 0.9× 201 1.0× 89 0.5× 53 1.3k
Yoichiro Takayanagi Japan 21 538 1.3× 619 1.9× 111 0.4× 380 1.8× 137 0.7× 60 1.3k
Minji Bang South Korea 20 316 0.8× 242 0.7× 101 0.4× 158 0.8× 144 0.8× 79 1.0k
J.R. DeQuardo United States 21 860 2.1× 443 1.3× 155 0.6× 206 1.0× 208 1.1× 54 1.4k
Masahito Nakataki Japan 19 246 0.6× 244 0.7× 242 0.9× 118 0.6× 86 0.5× 44 924

Countries citing papers authored by Satsuki Sumitani

Since Specialization
Citations

This map shows the geographic impact of Satsuki Sumitani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satsuki Sumitani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satsuki Sumitani more than expected).

Fields of papers citing papers by Satsuki Sumitani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satsuki Sumitani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satsuki Sumitani. The network helps show where Satsuki Sumitani may publish in the future.

Co-authorship network of co-authors of Satsuki Sumitani

This figure shows the co-authorship network connecting the top 25 collaborators of Satsuki Sumitani. A scholar is included among the top collaborators of Satsuki Sumitani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satsuki Sumitani. Satsuki Sumitani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tomotake, Masahito, Tsunehiko Tanaka, Shinya Watanabe, et al.. (2018). Relationship between social and cognitive functions in people with schizophrenia. Neuropsychiatric Disease and Treatment. Volume 14. 2215–2224. 19 indexed citations
2.
Sumitani, Satsuki, et al.. (2017). Prefrontal cortex activation during neuropsychological tasks might predict response to pharmacotherapy in patients with obsessive–compulsive disorder. Neuropsychiatric Disease and Treatment. Volume 13. 577–583. 8 indexed citations
3.
4.
Numata, Shusuke, Hidehiro Umehara, Makoto Kinoshita, et al.. (2016). No association between BDNFVal66Met polymorphism and treatment response in obsessive-compulsive disorder in the Japanese population. Neuropsychiatric Disease and Treatment. 12. 611–611. 8 indexed citations
5.
Iga, Jun‐ichi, et al.. (2014). Psychiatric symptoms in a patient with isolated adrenocorticotropin deficiency: case report and literature review. General Hospital Psychiatry. 36(4). 449.e3–449.e5. 5 indexed citations
6.
Sumitani, Satsuki, et al.. (2012). Multi‐channel near‐infrared spectroscopy shows reduced activation in the prefrontal cortex during facial expression processing in pervasive developmental disorder. Psychiatry and Clinical Neurosciences. 66(1). 26–33. 16 indexed citations
7.
Taniguchi, Kyoko, et al.. (2012). Multi-channel near-infrared spectroscopy reveals reduced prefrontal activation in schizophrenia patients during performance of the kana Stroop task. The Journal of Medical Investigation. 59(1,2). 45–52. 18 indexed citations
8.
Kinoshita, Makoto, Shusuke Numata, Atsushi Tajima, et al.. (2012). DNA Methylation Signatures of Peripheral Leukocytes in Schizophrenia. NeuroMolecular Medicine. 15(1). 95–101. 59 indexed citations
9.
Tomotake, Masahito, Tsunehiko Tanaka, Y Kaneda, et al.. (2010). Quality of life and cognitive dysfunction in people with schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 35(1). 53–59. 50 indexed citations
10.
Tayoshi, Shin’Ya, Masahito Nakataki, Satsuki Sumitani, et al.. (2009). GABA concentration in schizophrenia patients and the effects of antipsychotic medication: A proton magnetic resonance spectroscopy study. Schizophrenia Research. 117(1). 83–91. 90 indexed citations
11.
Tayoshi, Shin’Ya, Satsuki Sumitani, Kyoko Taniguchi, et al.. (2008). Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS). Schizophrenia Research. 108(1-3). 69–77. 94 indexed citations
12.
Numata, Shusuke, Shuichi Ueno, Jun‐ichi Iga, et al.. (2008). Positive association of the PDE4B (phosphodiesterase 4B) gene with schizophrenia in the Japanese population. Journal of Psychiatric Research. 43(1). 7–12. 43 indexed citations
13.
Kinouchi, Sawako, Jun‐ichi Iga, Shuichi Ueno, et al.. (2008). FKBP5, SERT and COMT mRNA expressions in the peripheral leukocytes during menstruation cycle in healthy reproductive females. Neuroscience Letters. 434(1). 124–128. 8 indexed citations
14.
Numata, Shusuke, Jun‐ichi Iga, Masahito Nakataki, et al.. (2008). Gene expression and association analyses of the phosphodiesterase 4B (PDE4B) gene in major depressive disorder in the Japanese population. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 150B(4). 527–534. 25 indexed citations
15.
Yamauchi, Ken, Masahito Tomotake, Jun‐ichi Iga, et al.. (2008). Predictors of subjective and objective quality of life in outpatients with schizophrenia. Psychiatry and Clinical Neurosciences. 62(4). 404–411. 77 indexed citations
16.
Song, Hongwei, Shuichi Ueno, Shusuke Numata, et al.. (2007). Association between PNPO and schizophrenia in the Japanese population. Schizophrenia Research. 97(1-3). 264–270. 9 indexed citations
17.
Shibuya‐Tayoshi, Sumiko, Shin’Ya Tayoshi, Satsuki Sumitani, et al.. (2007). Lithium effects on brain glutamatergic and GABAergic systems of healthy volunteers as measured by proton magnetic resonance spectroscopy. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32(1). 249–256. 35 indexed citations
18.
Numata, Shusuke, Shuichi Ueno, Jun‐ichi Iga, et al.. (2006). Interaction between catechol-O-methyltransferase (COMT) Val108/158Met and brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in age at onset and clinical symptoms in schizophrenia. Journal of Neural Transmission. 114(2). 255–259. 23 indexed citations
19.
Numata, Shusuke, Shuichi Ueno, Jun‐ichi Iga, et al.. (2006). Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Neuroscience Letters. 401(1-2). 1–5. 88 indexed citations
20.
Sumitani, Satsuki, Masafumi Harada, Hitoshi Kubo, & Tetsuro Ohmori. (2006). Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive–compulsive disorder patients. Psychiatry Research Neuroimaging. 154(1). 85–92. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shin’Ya Tayoshi Breakdown of academic impact, for papers by Malte S. Depping Breakdown of academic impact, for papers by Henning Witthaus Breakdown of academic impact, for papers by Anna Walter Breakdown of academic impact, for papers by Clifford Cassidy Breakdown of academic impact, for papers by Jun Ku Chung Breakdown of academic impact, for papers by Yoichiro Takayanagi Breakdown of academic impact, for papers by Minji Bang Breakdown of academic impact, for papers by J.R. DeQuardo Breakdown of academic impact, for papers by Masahito Nakataki
Rankless by CCL
2026